Many cancer drugs remain unproven five years after accelerated approval, a study finds | News, Sports, Jobs
The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs act
Source: newsandsentinel.com